Cargando…

A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy‐treated head and neck squamous cell carcinoma (HNSCC)

Previously, we have shown that copy number gain of the chromosomal band 16q24.3 is associated with impaired clinical outcome of radiotherapy‐treated head and neck squamous cell carcinoma (HNSCC) patients. We set out to identify a prognostic mRNA signature from genes located on 16q24.3 in radio(chemo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wintergerst, Ludmila, Selmansberger, Martin, Maihoefer, Cornelius, Schüttrumpf, Lars, Walch, Axel, Wilke, Christina, Pitea, Adriana, Woischke, Christine, Baumeister, Philipp, Kirchner, Thomas, Belka, Claus, Ganswindt, Ute, Zitzelsberger, Horst, Unger, Kristian, Hess, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275282/ https://www.ncbi.nlm.nih.gov/pubmed/30259648 http://dx.doi.org/10.1002/1878-0261.12388

Ejemplares similares

Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
por: Maihoefer, Cornelius, et al.
Publicado: (2018)

Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
por: Schüttrumpf, Lars, et al.
Publicado: (2020)

Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients
por: Hess, Julia, et al.
Publicado: (2022)

Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells
por: Summerer, Isolde, et al.
Publicado: (2015)

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015)

A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
por: Niyazi, Maximilian, et al.
Publicado: (2016)

The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Fazel, Asita, et al.
Publicado: (2020)

Planned neck dissection following chemo-radiotherapy in advanced HNSCC
por: Gupta, Tejpal, et al.
Publicado: (2004)

Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas
por: Schinke, Henrik, et al.
Publicado: (2020)

DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score
por: Unger, Kristian, et al.
Publicado: (2023)

Establishment and Molecular Cytogenetic Characterization of a Cell Culture Model of Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Bauer, Verena L., et al.
Publicado: (2010)

Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2013)

Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2015)

Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sections
por: Kreutzer, Lisa, et al.
Publicado: (2022)

Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks
por: Michna, Agata, et al.
Publicado: (2016)

Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy
por: Puntigam, Lisa K., et al.
Publicado: (2020)

Radiotherapy and "new" drugs-new side effects?
por: Niyazi, Maximilian, et al.
Publicado: (2011)

Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis
por: Savic, Dragana, et al.
Publicado: (2023)

Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
por: Szuecs, Marcella, et al.
Publicado: (2015)

Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
por: Leger, Stefan, et al.
Publicado: (2020)

High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma
por: Baumeister, Philipp, et al.
Publicado: (2018)

Integration of a radiation biomarker into modeling of thyroid carcinogenesis and post-Chernobyl risk assessment
por: Kaiser, Jan Christian, et al.
Publicado: (2016)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
por: Rabasco Meneghetti, Asier, et al.
Publicado: (2022)

Natural Cubic Spline Regression Modeling Followed by Dynamic Network Reconstruction for the Identification of Radiation-Sensitivity Gene Association Networks from Time-Course Transcriptome Data
por: Michna, Agata, et al.
Publicado: (2016)

Transcriptome network of the papillary thyroid carcinoma radiation marker CLIP2
por: Selmansberger, Martin, et al.
Publicado: (2020)

Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)
por: Skvortsov, S, et al.
Publicado: (2014)

(18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
por: Wiltgen, Tun, et al.
Publicado: (2022)

Surgery vs. radiotherapy in localized prostate cancer. Which is best?
por: Welz, Stefan, et al.
Publicado: (2008)

Choline PET based dose-painting in prostate cancer - Modelling of dose effects
por: Niyazi, Maximilian, et al.
Publicado: (2010)

Intra-fraction motion of the prostate is not increased by patient couch shifts
por: Ballhausen, Hendrik, et al.
Publicado: (2016)

miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells
por: Vahabi, Mahrou, et al.
Publicado: (2019)

Recurrence pattern analysis after [(68)Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas
por: Zollner, Barbara, et al.
Publicado: (2018)

Systematic risk analysis of radiation pneumonitis in breast cancer: role of cotreatment with chemo-, endocrine, and targeted therapy
por: Mangesius, Julian, et al.
Publicado: (2022)

Magnificat in D, BWV. 243 /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1991)

Magnificat in D, BWV 243 /
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1988)

Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma
por: Simonetto, Cristoforo, et al.
Publicado: (2020)

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
por: Glatzer, Markus, et al.
Publicado: (2016)

Preoperative Radio(Chemo)Therapy in Breast Cancer: Time to Switch the Perspective?
por: Montero, Angel, et al.
Publicado: (2022)

Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis
por: Walter, Franziska, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_49aeqeda5s4n68581dfdosvgrs